1. Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer
    Somayeh Hashemi Sheikhshabani et al, 2024, Cancer Reports CrossRef
  2. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions
    Pierre Vanden Borre et al, 2017, The Oncologist CrossRef
  3. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
    Anna F. Farago et al, 2015, Journal of Thoracic Oncology CrossRef
  4. Infantile NTRK-associated Mesenchymal Tumors
    Jessica L Davis et al, 2018, Pediatric and Developmental Pathology CrossRef
  5. Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
    Daniel Richard Gomez et al, 2018, Oncotarget CrossRef
  6. ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature
    Wusheng Zhang et al, 2024, Clinical Lung Cancer CrossRef
  7. Neurotrophic Tyrosine Kinase Gene Fusions: Another Opportunity for Targeting in Lung Cancer
    Luis E Raez et al, 2016, Lung Cancer Management CrossRef
  8. The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer
    Francesco Passiglia et al, 2016, Expert Opinion on Investigational Drugs CrossRef
  9. Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
    Yang Yang et al, 2016, Oncology Letters CrossRef
  10. New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions
    Christian Rolfo et al, 2017, Laboratory Investigation CrossRef
  11. Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
    Elke Tatjana Aristizabal Prada et al, 2018, Endocrine-Related Cancer CrossRef
  12. Targeting tropomyosin receptor kinase for cancer therapy
    Qi Miao et al, 2019, European Journal of Medicinal Chemistry CrossRef
  13. Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
    Mariana Petaccia de Macedo et al, 2023, Clinical Pathology CrossRef
  14. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
    C. Marchiò et al, 2019, Annals of Oncology CrossRef
  15. β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer
    Hani Lee et al, 2018, Oncogene CrossRef
  16. Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence
    Biagio Ricciuti et al, 2017, Medical Oncology CrossRef
  17. Loss of YAP1 defines neuroendocrine differentiation of lung tumors
    Takeshi Ito et al, 2016, Cancer Science CrossRef
  18. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts
    Xiaodong Ma et al, 2018, European Journal of Medicinal Chemistry CrossRef
  19. Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer
    Nicole Pinto et al, 2014, Journal of Oncology CrossRef
  20. Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt-related transcription factor 2
    YUXIANG LIAO et al, 2016, Molecular Medicine Reports CrossRef
  21. Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
    Chunwei Xu et al, 2022, Thoracic Cancer CrossRef
  22. Pulmonary Large-Cell Neuroendocrine Carcinoma: Therapeutic Challenges and Opportunities
    Georgios Ioannidis, 2020, Forum of Clinical Oncology CrossRef
  23. Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases
    Melinda Wuest et al, 2022, EJNMMI Research CrossRef
  24. Targeting TRK family proteins in cancer
    Yekaterina B. Khotskaya et al, 2017, Pharmacology & Therapeutics CrossRef
  25. Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
    Koen De Winne et al, 2021, Virchows Archiv CrossRef